Unsal, C. Et Al. 2013. Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine. NEUROPSYCHIATRIC DISEASE AND TREATMENT , vol.9 , 1545-1552.

Unsal, C., Albayrak, Y., Albayrak, N., Kuloglu, M., & Hashimoto, K., (2013). Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine. NEUROPSYCHIATRIC DISEASE AND TREATMENT , vol.9, 1545-1552.

Unsal, Cuneyt Et Al. "Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine," NEUROPSYCHIATRIC DISEASE AND TREATMENT , vol.9, 1545-1552, 2013

Unsal, Cuneyt Et Al. "Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine." NEUROPSYCHIATRIC DISEASE AND TREATMENT , vol.9, pp.1545-1552, 2013

Unsal, C. Et Al. (2013) . "Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine." NEUROPSYCHIATRIC DISEASE AND TREATMENT , vol.9, pp.1545-1552.

@article{article, author={Cuneyt Unsal Et Al. }, title={Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine}, journal={NEUROPSYCHIATRIC DISEASE AND TREATMENT}, year=2013, pages={1545-1552} }